NCPDP Annual Conference 2026

Closing Keynote Panel

Federal Perspectives, National Impact: Interoperability Policy and What It Means for Pharmacy with HHS Leadership

Wednesday, May 6, 2026 | 1:15 - 3:30 pm PT

Federal leadership is taking center stage at the 2026 Annual Technology & Business Conference with an interactive session featuring senior leaders from HHS, CMS, FDA, and ASTP/ONC. Attendees will gain firsthand insight into national interoperability priorities, TEFCA progress, CMS data modernization efforts, Medicare coverage expansion for GLP1 therapies, and more!

This closing session is designed as an interactive program with an open Q&A featuring expanded HHS leadership. This session highlights the real-world policy decisions shaping pharmacy operations, health IT implementation, and patient access…it is a must-attend experience for all attendees!

Thomas Keane, MD, MBA
National Coordinator for Health IT, US Department of Health and Human Services (HHS)

Dr. Thomas Keane serves as the ninth National Coordinator for Health Information Technology. An engineer and physician, Dr. Keane previously served in ONC and also as a Senior Advisor to the Deputy Secretary of HHS. Among other duties, he was an administrator of the COVID-19 Provider Relief Fund and lead the development of the AHRQ National Nursing Home COVID Action Network. Dr. Keane worked as a finite element software developer and enterprise software engineer prior to training as an interventional radiologist.

Amy Gleason
Acting Administrator of the U.S. DOGE Service and Strategic Advisor to the Centers for Medicare & Medicaid Services (CMS)

Amy Gleason is the Acting Administrator of the U.S. DOGE Service and Strategic Advisor to the Centers for Medicare & Medicaid Services (CMS), where she leads national initiatives to modernize healthcare technology and improve data interoperability. Previously, she served as Chief Product Officer at Russell Street Ventures, where she led digital health innovation at Main Street Health and CareBridge. Amy also served with the U.S. Digital Service at the White House, where she created the national COVID-19 database and led major efforts such as the Pandemic Ready Interoperable Modernization Effort (PRIME) and Data at the Point of Care. She began her career in nursing and has spent her career advancing healthcare through technology. Amy brings a deeply personal perspective to her work, shaped by her experience as a caregiver to her daughter, who was diagnosed with a rare disease at age 11.

Julian Chun, PharmD, MBA 
Consumer Safety Officer, Drug Registration and Listing System Office of Compliance
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Julian Chun is a Consumer Safety Officer with the Drug Registration and Listing branch at the U.S. Food and Drug Administration. Prior to his current position, Julian served in managerial and clinical roles for Johns Hopkins Outpatient Pharmacy and Giant Pharmacy. Julian received his Pharm.D. from University of Maryland and an MBA degree from Johns Hopkins University. He holds a specialty board certification in ambulatory care pharmacy and a regulatory affairs certification in drugs.

Shelly Winston, MBA
Director of Payment Reconciliation for Medicare Part D, Centers for Medicare and Medicaid Services (CMS)

Shelly Winston joined the Centers for Medicare and Medicaid Services (CMS) in 2010, and she is currently the Director of Payment Reconciliation for Medicare Part D. Shelly began working with NCPDP when she was assigned to manage Part D Coordination of Benefits in 2015. Since then, she has been instrumental in updating NCPDP SCRIPT, RTPB and ePA standards© for Medicare part D plans. She has become a fixture at NCPDP sessions and has worked with the industry to implement key statutory requirements such as the Coverage Gap Discount program, the Medicare Prescription Payment Plan, insulin cost sharing limits and complying with drug price negotiations. Shelly is now working with the industry to help reduce the provider burden associated with prescription electronic Prior Authorization.

NCPDP Annual Conference 2018

Closing Keynote Panel

Thomas Keane, MD, MBA
National Coordinator for Health IT, US Department of Health and Human Services (HHS)

Amy Gleason
Acting Administrator of the U.S. DOGE Service and Strategic Advisor to the Centers for Medicare & Medicaid Services (CMS)

Julian Chun, PharmD, MBA 
Consumer Safety Officer, Drug Registration and Listing System Office of Compliance
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Shelly Winston, MBA
Director of Payment Reconciliation for Medicare Part D, Centers for Medicare and Medicaid Services (CMS)

Need More Info?

Thomas Keane, MD, MBA National Coordinator for Health IT, US Department of Health and Human Services (HHS)

Amy Gleason Acting Administrator of the U.S. DOGE Service and Strategic Advisor to the Centers for Medicare & Medicaid Services (CMS)

Julian Chun, PharmD, MBA Consumer Safety Officer, Drug Registration and Listing System Office of Compliance Center for Drug Evaluation and Research U.S. Food and Drug Administration

Shelly Winston, MBA Director of Payment Reconciliation for Medicare Part D, Centers for Medicare and Medicaid Services (CMS)

Need More Info?

Thomas Keane, MD, MBA
National Coordinator for Health IT, US Department of Health and Human Services (HHS)

Amy Gleason
Acting Administrator of the U.S. DOGE Service and Strategic Advisor to the Centers for Medicare & Medicaid Services (CMS)

Julian Chun, PharmD, MBA 
Consumer Safety Officer, Drug Registration and Listing System Office of Compliance
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Shelly Winston, MBA
Director of Payment Reconciliation for Medicare Part D, Centers for Medicare and Medicaid Services (CMS)